The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, IO Biotech Inc (NASDAQ: IOBT) closed at $1.6 up 7.38% from its previous closing price of $1.49. In other words, the price has increased by $7.38 from its previous closing price. On the day, 1.69 million shares were traded. IOBT stock price reached its highest trading level at $1.63 during the session, while it also had its lowest trading level at $1.51.
Ratios:
For a deeper understanding of IO Biotech Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.96 and its Current Ratio is at 1.96. In the meantime, Its Debt-to-Equity ratio is 5.26 whereas as Long-Term Debt/Eq ratio is at 4.77.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 30 ’25 when Hunter Heidi bought 15,000 shares for $1.39 per share. The transaction valued at 20,884 led to the insider holds 15,000 shares of the business.
Ahmad Qasim Iftikhar bought 31,350 shares of IOBT for $26,553 on Dec 23 ’24. The Chief Medical Officer now owns 31,350 shares after completing the transaction at $0.85 per share. On Dec 23 ’24, another insider, Zocca Mai-Britt, who serves as the Chief Executive Officer of the company, bought 12,500 shares for $0.81 each. As a result, the insider paid 10,120 and bolstered with 49,891 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IOBT now has a Market Capitalization of 105409464 and an Enterprise Value of 85634464.
Stock Price History:
The Beta on a monthly basis for IOBT is 0.40, which has changed by 0.52380955 over the last 52 weeks, in comparison to a change of 0.16333759 over the same period for the S&P500. Over the past 52 weeks, IOBT has reached a high of $2.79, while it has fallen to a 52-week low of $0.66. The 50-Day Moving Average of the stock is -12.67%, while the 200-Day Moving Average is calculated to be 28.71%.
Shares Statistics:
For the past three months, IOBT has traded an average of 3.20M shares per day and 1255840 over the past ten days. A total of 65.88M shares are outstanding, with a floating share count of 49.27M. Insiders hold about 25.21% of the company’s shares, while institutions hold 20.21% stake in the company. Shares short for IOBT as of 1756425600 were 1229171 with a Short Ratio of 0.38, compared to 1753920000 on 851154. Therefore, it implies a Short% of Shares Outstanding of 1229171 and a Short% of Float of 3.8900003.
Earnings Estimates
The market rating of IO Biotech Inc (IOBT) is currently shaped by the ongoing analysis conducted by 1.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.31, with high estimates of -$0.26 and low estimates of -$0.45.
Analysts are recommending an EPS of between -$1.1 and -$1.1 for the fiscal current year, implying an average EPS of -$1.1. EPS for the following year is -$0.86, with 1.0 analysts recommending between -$0.86 and -$0.86.
